Literature DB >> 6335173

Cyclosporine therapy. Its significance to the periodontist.

T D Daley, G P Wysocki.   

Abstract

Cyclosporine is a relatively new immunosuppressive agent which has been used successfully to prevent organ transplant rejection, to treat type-I diabetes mellitus as well as several other autoimmune disorders. It is anticipated that the therapeutic use of cyclosporine will progressively increase in the future to include the treatment of numerous other disorders. As its clinical use broadens, more health professionals will need to become familiar with the beneficial effects as well as some of the undesirable side-effects of cyclosporine therapy. Two side-effects of the drug which are of interest to the periodontist are gingival hyperplasia and transient perioral hyperaesthesia. It is anticipated that the dental profession, particularly periodontists, will be called upon to help prevent, control or treat these side effects. The purpose of this paper is to familiarize the periodontist with cyclosporine and to discuss its anticipated impact on the practice of periodontics.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335173     DOI: 10.1902/jop.1984.55.12.708

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  6 in total

1.  High-turnover osteoporosis is induced by cyclosporin A in rats.

Authors:  Chie Wada; Masatoshi Kataoka; Hiroyuki Seto; Noriko Hayashi; Jun-ichi Kido; Yasuo Shinohara; Toshihiko Nagata
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 2.  Gingival enlargement induced by drugs.

Authors:  L Brunet; J Miranda; M Farré; L Berini; C Mendieta
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

3.  Down-regulation of transforming growth factor beta-2 expression is associated with the reduction of cyclosporin induced gingival overgrowth in rats treated with roxithromycin: an experimental study.

Authors:  Simone Aparecida Probst Condé; Marcus Gomes Bastos; Beatriz Julião Vieira; Fernando Monteiro Aarestrup
Journal:  BMC Oral Health       Date:  2009-12-08       Impact factor: 2.757

4.  Development and Validation of a RP-HPLC Method for Determination of Cyclosporine in Capsule.

Authors:  F Aziz; A Gupta; M F Khan
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

Review 5.  Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis.

Authors:  R S Brown; P R Arany
Journal:  Oral Dis       Date:  2014-08-07       Impact factor: 3.511

6.  Effect of phenytoin and age on gingival fibroblast enzymes.

Authors:  Surena Vahabi; Bahareh Nazemisalman; Mojtaba Vahid Golpaigani; Anahid Ahmadi
Journal:  J Dent (Tehran)       Date:  2014-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.